U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07296458) titled 'FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy' on Nov. 14.
Brief Summary: The goal of this clinical trial is to learn if the drug Fenofibrate works to treat adults with a liver disease called Primary Biliary Cholangitis (PBC) who have not received previous treatment. It will also learn about the safety of Fenofibrate. The main questions it aims to answer are:
Is Fenofibrate better at helping the liver return to normal function (measured by a blood test called ALP) than the standard medication, Ursodeoxycholic What kind of medical problems do participants have when taking Fenofibrate compa...